Skip to main content
Donald Kohn, MD, Pediatrics, Los Angeles, CA, Ronald Reagan UCLA Medical Center

DonaldBarryKohnMD

Pediatrics Los Angeles, CA

Professor, Pediatrics, UCLA School of Medicine

Dr. Kohn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kohn's full profile

Already have an account?

  • Office

    UCLA Department of Pediatrics Hematology/Oncology Division
    10833 Le Conte Ave., Rm A2-410 MDCC
    Los Angeles, CA 90095
    Phone+1 310-825-6708
    Fax+1 310-825-6708
  • Is this information wrong?

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Allergy and Immunology, 1986 - 1988
  • University of Wisconsin Hospitals and Clinics
    University of Wisconsin Hospitals and ClinicsResidency, Pediatrics, 1982 - 1985
  • University of Wisconsin School of Medicine & Public Health
    University of Wisconsin School of Medicine & Public HealthClass of 1982

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1987 - 2025
  • WI State Medical License
    WI State Medical License 1983 - 2017
  • American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • T Cell Dynamics and Response of the Microbiota After Gene Therapy to Treat X-linked Severe Combined Immunodeficiency  
    Luigi D Notarangelo, Judith Kelsen, Ronald G Collman, Donald B Kohn, BioMed Central
  • IND-Enabling Studies for a Clinical Trial to Genetically Program a Persistent Cancer-Targeted Immune System  
    Kenneth Cornetta, Antoni Ribas, Gay M Crooks, Donald B Kohn, Clinical Cancer Research

Lectures

  • Friday Scientific Workshop on Novel Curative Options: Gene-Editing and Gene Therapy for Hemoglobinopathies with a Focus on Sickle Cell Disease 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Completing the Genome Editing Arc in Hematology 
    60th American Society of Hematology Annual Meeting - 12/4/2018

Press Mentions

  • UCLA-Led Study Uses Base Editing to Correct Mutation That Causes Rare Immune Deficiency
    UCLA-Led Study Uses Base Editing to Correct Mutation That Causes Rare Immune DeficiencyMarch 20th, 2023
  • A Gene Therapy Cure for Sickle Cell Is on the Horizon
    A Gene Therapy Cure for Sickle Cell Is on the HorizonMarch 15th, 2023
  • Kids with 'Bubble Boy' Disease Could Finally Get Access to a Life-Saving Gene Therapy, as a Study Starts Back up at UCLA
    Kids with 'Bubble Boy' Disease Could Finally Get Access to a Life-Saving Gene Therapy, as a Study Starts Back up at UCLADecember 27th, 2022
  • Join now to see all

Grant Support

  • Transduction Of Hematopoietic Stem Cells For Enhanced Immunotherapy Of MelanomaNational Cancer Institute2010–2012
  • Training In Developmental HematologyNational Heart, Lung, And Blood Institute2011
  • In Vivo ADA Gene Delivery For The Treatment Of SCIDNational Institute Of Allergy And Infectious Diseases2009–2011
  • Gene Therapy Using Hematopoietic Stem CellsNational Heart, Lung, And Blood Institute2009–2011
  • In Vivo ADA Gene Delivery For The Treatment Of SCIDNational Center For Research Resources2009–2011
  • Mnd-Ada Transduced CD34 Cells For Ada-ScidFood And Drug Administration2005–2011
  • Clinical Trial: Transduction Of CD34+ Cells From The Umbilical Cord Blood Of InfNational Center For Research Resources2009
  • Clinical Trial: Long-Term Follow-Up For Studies Of Gene Transfer (Hiv And OthersNational Center For Research Resources2009
  • Lentiviral Vector For Gene Transfer To Hematopoietic Stem CellsNational Center For Research Resources2007–2009
  • In Vivo ADA Gene Delivery For The Treatment Of SCIDNational Institute Of Allergy And Infectious Diseases2007–2008
  • Long-Term Follow-Up For Studies Of Gene Transfer (Hiv And Others)National Center For Research Resources2007–2008
  • Conference--American Society Of Gene TherapyNational Heart, Lung, And Blood Institute2004–2008
  • Transduction Of CD34+ Cells From The Umbilical Cord Blood Of Infants Or The BNational Center For Research Resources2006–2007
  • Gene Therapy For Ada-Deficient SCIDNational Heart, Lung, And Blood Institute2004–2007
  • Gene Therapy Using Hematopoietic Stem CellsNational Heart, Lung, And Blood Institute2003–2007
  • Clinical Trial Planning Grant: Lentiviral Vector For HIV-1National Institute Of Allergy And Infectious Diseases2006
  • Long-Term Follow-Up For Studies Of Gene TransferNational Center For Research Resources2005–2006
  • Lentiviral Vector Transfer To Hematopoietic Stem CellsNational Center For Research Resources2003–2006
  • Treatment Of Severe Combined Immune Deficiency Disease Due To ADA DeficiencyNational Center For Research Resources2005
  • Mnd-Ada Transduced CD34 Cells For Ada-ScidFood And Drug Administration2005
  • Lentiviral Vector Transfer To Hematopoietic Stem CellsNational Institute Of Allergy And Infectious Diseases2002–2005
  • Core A-- Administrative CoreNational Heart, Lung, And Blood Institute2004
  • Treatment Of Severe Combined Immune Deficiency DiseaseNational Center For Research Resources2004
  • Transfer Of Revm10 And FX Genes Into Bone MarrowNational Center For Research Resources2004
  • Transduction Of CD34+ Cells From The Bone Marrow Of HIV-1 Infected ChildrenNational Center For Research Resources1998–2004
  • Gene Expression In Beta-Cells By Lentiviral VectorsNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2003
  • Core--Gene Transduction And Gene TherapyNational Heart, Lung, And Blood Institute2000–2002
  • Retrovirus And Lentivirus For Stem Cell TransductionNational Institute Of Allergy And Infectious Diseases1999–2002
  • In Vitro And In Vivo Models Of Human ErythropoiesisNational Heart, Lung, And Blood Institute1998–2002
  • Transduction Of CD34 Peripheral Blood Progenital Cell From HIV Infected PersonsNational Center For Research Resources1998–2002
  • Mechanisms Of Gene SilencingNational Cancer Institute1996–2002
  • Core--Vector DevelopmentNational Cancer Institute1996–2002
  • Gene Therapy For Hurlers DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases1998–2001
  • Hematopoietic Stem Cells For Gene Therapy With REV M10National Institute Of Allergy And Infectious Diseases1998–2001
  • Modified Retroviral Vectors For HSC Gene TherapyNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2000
  • Treatment Of Severe Combined Immunodeficiency Disease Due To ADA DeficiencyNational Center For Research Resources1997–1999
  • In Vivo Model For Human Stem CellsNational Heart, Lung, And Blood Institute1996–1999
  • Core--Gene Therapy/Molecular Biology LaboratoryNational Heart, Lung, And Blood Institute1996–1999
  • Retroviral Transfer Of CDNA For Glucocerebrosidase Into Stem CellsNational Center For Research Resources1996–1999
  • Retroviral Transduction Of Anti-Hiv Ribozyme Into Hematopoietic Stem CellsNational Institute Of Allergy And Infectious Diseases1996–1998
  • Hematopoietic Gene Transfer--Pediatric AIDSNational Institute Of Allergy And Infectious Diseases1996–1997
  • Modified Retroviral Vectors For Stable Gene ExpressionNational Institute Of Diabetes And Digestive And Kidney Diseases1994–1996
  • In Vivo Model Of Human Stem Cell Gene TherapyNational Institute Of Diabetes And Digestive And Kidney Diseases1994–1995
  • Glucocerebrosidase Gene Expression--Hematopoietic CellsNational Institute Of Diabetes And Digestive And Kidney Diseases1994
  • Glucocerebrosidase Gene Expression-Hematopoietic CellsNational Institute Of Diabetes And Digestive And Kidney Diseases1991–1993
  • Retroviral Vector-Mediated Transfer Of Nef GeneNational Institute Of Allergy And Infectious Diseases1989–1991

Hospital Affiliations